These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22883390)

  • 41. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of diabetes: Crossing to the other side.
    Skliros NP; Vlachopoulos C; Tousoulis D
    Hellenic J Cardiol; 2016; 57(5):304-310. PubMed ID: 27687958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Differential therapy with oral antidiabetic drugs].
    Mehnert H
    Med Klin (Munich); 1991 Oct; 86(10):521-5. PubMed ID: 1758375
    [No Abstract]   [Full Text] [Related]  

  • 44. Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan.
    Hsiao PJ; Wu KL; Chiu SH; Chan JS; Lin YF; Wu CZ; Wu CC; Kao S; Fang TC; Lin SH; Chen JS
    Clin Exp Nephrol; 2017 Aug; 21(4):694-704. PubMed ID: 27599981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early recurrence of Type 2 diabetic nephropathy after kidney transplantation.
    Tinel C; Martin L; Cabanne JF; Tanter Y; Rifle G; Mousson C
    Clin Nephrol; 2011 Feb; 75(2):179-80. PubMed ID: 21255550
    [No Abstract]   [Full Text] [Related]  

  • 46. Introduction.
    Dahlöf B; Ritz E
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S1-2. PubMed ID: 15868114
    [No Abstract]   [Full Text] [Related]  

  • 47. Insulin therapy in renal disease.
    Iglesias P; Díez JJ
    Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetes complications. Proactive care a must.
    Mayo Clin Health Lett; 2012 Oct; 30(10):4-5. PubMed ID: 23133856
    [No Abstract]   [Full Text] [Related]  

  • 49. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
    Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
    J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Oral hypoglycemic agents and metformin in the treatment of type II non-insulin-dependent diabetes].
    Isnard F
    Sem Hop; 1983 Dec; 59(49):3437-8. PubMed ID: 6320423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Guidelines for the treatment of arterial hypertension in diabetes mellitus. The consensus recommendations of the German League for the Fight against High Blood Pressure, Inc., the German Diabetes Society and the Society for Nephrology].
    Schäfers RF; Lütkes P; Ritz E; Philipp T
    Dtsch Med Wochenschr; 1999 Nov; 124(45):1356-72. PubMed ID: 10592780
    [No Abstract]   [Full Text] [Related]  

  • 52. Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise.
    Li XC; Zhuo JL
    Clin Sci (Lond); 2007 Aug; 113(4):183-93. PubMed ID: 17623014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and Management of Type 2 Diabetic Kidney Disease.
    Doshi SM; Friedman AN
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1366-1373. PubMed ID: 28280116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of oral glucose-lowering agents in patients with renal impairment].
    Scheen AJ
    Rev Med Suisse; 2012 Aug; 8(351):1614-20. PubMed ID: 22988715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of Classes of Antihyperglycemic Agents in People With Type 2 Diabetes Based on Level of Estimated Glomerular Filtration Rate.
    ; Gilbert J; McFarlane P; Kim J; Jin S; Senior P; ; ; Gilbert J; Bajaj HS; Jin S; Kim J; ; Bajaj HS; Gilbert J; Houlden R; Kim J; MacDonald B; MacKay D; Mansell K; Rabi D; Sherifali D; Senior P
    Can J Diabetes; 2023 Apr; 47(3):223-227. PubMed ID: 36842879
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions.
    Amin M; Suksomboon N
    Drug Saf; 2014 Nov; 37(11):903-19. PubMed ID: 25249046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The therapy in obese diabetic type 2 patients].
    Rušavý Z
    Vnitr Lek; 2014 Oct; 60(10):819-20. PubMed ID: 25612341
    [No Abstract]   [Full Text] [Related]  

  • 58. Antidiabetic drugs and neuroendocrine neoplasms: a double-edged sword?
    Dicitore A
    Minerva Med; 2021 Dec; 112(6):683-685. PubMed ID: 35168303
    [No Abstract]   [Full Text] [Related]  

  • 59. New Antidiabetic Therapies: A Paradigm Shift in Type 2 Diabetes Management.
    Koufakis T; Katsiki N; Kotsa K
    Curr Pharm Des; 2021; 27(8):1007. PubMed ID: 33849410
    [No Abstract]   [Full Text] [Related]  

  • 60. Maximally utilizing the available agents for the treatment of type 2 diabetes.
    Bell DS
    Clin Med Res; 2003 Jul; 1(3):173-4. PubMed ID: 15931306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.